Could a simple girdle ease pelvic organ prolapse discomfort?
NCT ID NCT00964197
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a pelvic support girdle called FemmeJock in 100 women with pelvic organ prolapse. Participants wore the girdle during daytime physical activity for 3 months. The goal was to see if it improved symptoms like pelvic pressure and bulging, and whether women were satisfied enough to keep using it. This is a small pilot study, so results are preliminary.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- FemmeJock pelvic support girdle
- What this could lead to
- If it works, this could offer a non-surgical, drug-free option to ease pelvic pressure and discomfort for women with prolapse.
- What could go wrong
- This is a small pilot study with no control group, so results may not be conclusive. The device may not work for everyone, and long-term benefits are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
100 people
The number who actually took part.
- Start date
-
Nov 2008
- Finished
-
Apr 2014
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 99 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Pelvic organ prolapse, \> stage II * 1 or more prolapse associated symptoms: * Herniation symptoms * Pelvic pressure * Bulging tissue * Sexual dysfunction * Patient willingness to enroll * Available for 3 months of follow-up Exclusion Criteria: * Pregnancy or planning pregnancy within the next 3 months * Perineal ulcers or trauma * Anticipating relocation in next 3 months * Current pessary use * Dementia or inability to complete questionnaires * Chronic inflammatory or infectious vulvar condition (i.e., dermatologic conditions: lichen sclerosis or lichen planus, or vulvar candidiasis)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pelvic organ prolapse are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can strength training steady the walk and strengthen the pelvic floor after menopause?
- Can a biological mesh improve pelvic floor surgery?
- Can targeted exercises ease mild pelvic organ prolapse without surgery?
- AI may predict which pelvic floor therapy works best
- Can a small pressure drop make prolapse surgery less painful?
- Could a simple surgical step make hysterectomies safer?